Prehospital Tranexamic Acid (TXA) in Patients with Traumatic Brain Injury (TBI).
Transfusion Medicine Reviews · 2021-09-04 · Other / unclear
Abstract
Traumatic brain injury (TBI) remains a significant medical and socioeconomic challenge. The initial injury may be complicated by haemostatic derangements leading to exacerbation of lesions and haemorrhagic progression. The results from the CRASH-3 trial have promoted the implementation of the antifibrinolytic tranexamic acid (TXA) into prehospital Emergency Medical Services (EMS) protocols. Very recently, the efficacy and safety of early out-of-hospital TXA compared to placebo was assessed in patients with moderate or severe TBI in a prospective, multicenter phase II trial, e.g. "The Prehospital TXA for TBI"-trial. Simultaneously, the results from a retrospective analysis of prospectively collected observational data into the Dutch pre-hospital TBI database were published which had assessed whether prehospital administration of TXA may be associated with mortality and functional outcomes in patients with severe TBI. Both studies are reviewed against their limitations and windows of opportunity are highlighted.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Haemostatics · Tranexamic acid
Related articles
- Prehospital Pharmacotherapy in Moderate and Severe Traumatic Brain Injury: A Systematic Review. (Med J (Ft Sam Houst Tex), 2023)
- Association between coagulation biomarkers, intracranial hemorrhage types, and tranexamic acid treatments in early traumatic brain injury. (J Trauma Acute Care Surg, 2025)
- Enrollment with and without exception from informed consent in a pilot trial of tranexamic acid in children with hemorrhagic injuries. (Acad Emerg Med, 2021)
- Tranexamic acid administration in the field does not affect admission thromboelastography after traumatic brain injury. (J Trauma Acute Care Surg, 2020)
- Intravenous Tranexamic Acid for Subdural and Epidural Intracranial Hemorrhage: Randomized, Double-Blind, Placebo-Controlled Trial. (Rev Recent Clin Trials, 2019)
- Benefits of the tranexamic acid in head trauma with no extracranial bleeding: a prospective follow-up of 180 patients. (Eur J Trauma Emerg Surg, 2019)